RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Sanara Medtech Stock

Sanara Medtech EBIT 2024

Sanara Medtech EBIT

-6.32 M USD

Ticker

SMTI

ISIN

US79957L1008

In 2024, Sanara Medtech's EBIT was -6.32 M USD, a 50.03% increase from the -4.22 M USD EBIT recorded in the previous year.

The Sanara Medtech EBIT history

YEAREBIT (undefined USD)
2025e-714
2024e-6,324
2023-4,215.16
2022-12,040
2021-7,380
2020-5,040
2019-2,740
2018-500
2017120
2016-270
2015-960
2014-2,060
2013-2,930
2012-5,390
2011-1,810
2010-2,470
2009-1,510
2008-1,760
2007-410

Sanara Medtech Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Sanara Medtech, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Sanara Medtech from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Sanara Medtech’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Sanara Medtech. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Sanara Medtech’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Sanara Medtech’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Sanara Medtech’s growth potential.

Sanara Medtech Revenue, EBIT and net profit per share

DateSanara Medtech RevenueSanara Medtech EBITSanara Medtech Net Income
2025e98.12 M undefined-714,000 undefined-10.44 M undefined
2024e82.52 M undefined-6.32 M undefined-18.12 M undefined
202364.99 M undefined-4.22 M undefined-4.3 M undefined
202245.84 M undefined-12.04 M undefined-7.94 M undefined
202124.14 M undefined-7.38 M undefined-7.92 M undefined
202015.59 M undefined-5.04 M undefined-4.36 M undefined
201911.77 M undefined-2.74 M undefined-2.81 M undefined
20185.84 M undefined-500,000 undefined-730,000 undefined
20176.3 M undefined120,000 undefined190,000 undefined
20165.51 M undefined-270,000 undefined-680,000 undefined
20153.37 M undefined-960,000 undefined-1.61 M undefined
20142.63 M undefined-2.06 M undefined-2.51 M undefined
20131.73 M undefined-2.93 M undefined-4.15 M undefined
20121.17 M undefined-5.39 M undefined-1.85 M undefined
20112.21 M undefined-1.81 M undefined-12.74 M undefined
2010910,000 undefined-2.47 M undefined-6.64 M undefined
2009290,000 undefined-1.51 M undefined-3.02 M undefined
2008290,000 undefined-1.76 M undefined-1.77 M undefined
2007630,000 undefined-410,000 undefined-540,000 undefined

Sanara Medtech stock margins

The Sanara Medtech margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Sanara Medtech. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Sanara Medtech.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Sanara Medtech's sales revenue. A higher gross margin percentage indicates that the Sanara Medtech retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Sanara Medtech's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Sanara Medtech's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Sanara Medtech's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Sanara Medtech. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Sanara Medtech's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Sanara Medtech Margin History

Sanara Medtech Gross marginSanara Medtech Profit marginSanara Medtech EBIT marginSanara Medtech Profit margin
2025e87.92 %-0.73 %-10.64 %
2024e87.92 %-7.66 %-21.96 %
202387.92 %-6.49 %-6.62 %
202286.13 %-26.27 %-17.32 %
202190.43 %-30.57 %-32.81 %
202089.61 %-32.33 %-27.97 %
201989.72 %-23.28 %-23.87 %
201891.27 %-8.56 %-12.5 %
201787.3 %1.9 %3.02 %
201682.76 %-4.9 %-12.34 %
201573.59 %-28.49 %-47.77 %
201469.58 %-78.33 %-95.44 %
201353.76 %-169.36 %-239.88 %
201232.48 %-460.68 %-158.12 %
201163.8 %-81.9 %-576.47 %
201040.66 %-271.43 %-729.67 %
2009-113.79 %-520.69 %-1,041.38 %
2008-44.83 %-606.9 %-610.34 %
200765.08 %-65.08 %-85.71 %

Sanara Medtech Aktienanalyse

What does Sanara Medtech do?

Sanara Medtech Inc is a leading company specializing in the development of innovative medical devices and solutions. The company is headquartered in Texas, USA and has experienced significant growth since its founding in 2014. Its areas of specialization include wound care, incontinence management, and dermatology. The history of Sanara Medtech Inc began in 2014 when a team of experienced medical technology experts founded the company. Leveraging their extensive industry knowledge and expertise, the team quickly identified a market niche and established themselves as a leading provider of innovative solutions. The business model of Sanara Medtech Inc is focused on developing medical devices and solutions that aim to improve the daily lives of patients and healthcare professionals. The company is committed to developing and manufacturing top-quality products that contribute to enhancing patient care and supporting healthcare professionals in their tasks. Sanara Medtech Inc offers a wide range of products tailored to the needs of patients and medical professionals. Its wound care products include wound dressings, wound healing ointments, and other specialized products for treating chronic and acute wounds. The incontinence management products include disposable and reusable incontinence products designed to improve the lives of individuals with incontinence issues. Dermatology products encompass a wide range of products for treating skin conditions such as psoriasis, eczema, and rosacea, to name a few. Another focus of Sanara Medtech Inc is collaborating with private and public healthcare facilities to ensure the availability of its products in hospitals, clinics, nursing homes, and other healthcare facilities. The company also offers training and educational programs for healthcare professionals to ensure proper product use. In summary, Sanara Medtech Inc is an innovative company specializing in the development of medical devices and solutions tailored to the needs of patients and healthcare professionals. Its goal is to develop top-quality products that contribute to the improvement of healthcare and enhance the lives of patients. With a wide range of products and a strong market presence, Sanara Medtech Inc is a leading force in the medical technology industry. Sanara Medtech ist eines der beliebtesten Unternehmen auf Eulerpool.com.

EBIT Details

Analyzing Sanara Medtech's EBIT

Sanara Medtech's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Sanara Medtech's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Sanara Medtech's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Sanara Medtech’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Sanara Medtech stock

How much did Sanara Medtech achieve in EBIT for the current year?

In the current year, Sanara Medtech has achieved an EBIT of -6.32 M USD.

What is EBIT?

EBIT stands for Earnings Before Interest and Taxes and refers to the profit before interest and taxes of a company Sanara Medtech.

How has the EBIT of Sanara Medtech developed in recent years?

The EBIT of Sanara Medtech has increased by 50.03% increased compared to the previous year.

What does EBIT mean for investors?

EBIT provides investors with insights into a company's profitability as it reflects the profit before interest expenses and taxes.

Why is EBIT an important indicator for investors?

Since EBIT provides a more direct insight into a company's profit than net income, it is an important indicator for investors to assess the profitability of a company.

Why do EBIT values fluctuate?

EBIT values can fluctuate as they are influenced by various factors, such as revenue, costs, and tax effects.

What role does tax burden play in EBIT?

Tax burdens have a direct impact on a company's EBIT, as they are deducted from the profit.

How is EBIT presented in the balance sheet of the company Sanara Medtech?

The EBIT of Sanara Medtech is listed in the income statement.

Can EBIT be used as a single indicator for evaluating a company?

EBIT is an important indicator for evaluating a company, but additional financial ratios should also be considered to get a comprehensive picture.

Why is EBIT not equal to net profit?

The net profit of a company includes taxes and interest, while EBIT represents the profit before interest and taxes.

How much dividend does Sanara Medtech pay?

Over the past 12 months, Sanara Medtech paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Sanara Medtech is expected to pay a dividend of 0 USD.

What is the dividend yield of Sanara Medtech?

The current dividend yield of Sanara Medtech is .

When does Sanara Medtech pay dividends?

Sanara Medtech pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Sanara Medtech?

Sanara Medtech paid dividends every year for the past 0 years.

What is the dividend of Sanara Medtech?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Sanara Medtech located?

Sanara Medtech is assigned to the 'Health' sector.

Wann musste ich die Aktien von Sanara Medtech kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Sanara Medtech from 9/25/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/25/2024.

When did Sanara Medtech pay the last dividend?

The last dividend was paid out on 9/25/2024.

What was the dividend of Sanara Medtech in the year 2023?

In the year 2023, Sanara Medtech distributed 0 USD as dividends.

In which currency does Sanara Medtech pay out the dividend?

The dividends of Sanara Medtech are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Sanara Medtech

Our stock analysis for Sanara Medtech Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Sanara Medtech Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.